Total medical devices industry cross border deals worth $475.7m were announced globally for November 2020, with Coloplast ’s $145m acquisition of Nine Continents Medical being the sector’s biggest investment, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 69.3% over the previous month and a drop of 83.01% when compared with the last 12-month average of $2.8bn.

In terms of number of cross border deals, the sector saw a drop of 39.47% with 23 deals in November 2020 when compared to the last 12-month average of 38 deals.

In value terms, North America led the activity with cross border deals worth $324.6m in November 2020.

medical devices industry cross border deals in November 2020: Top deals

The top five cross border deals accounted for 72.6% of the overall value during November 2020.

The combined value of the top five cross border deals stood at $345.27m, against the overall value of $475.7m recorded for the month.

The top five medical devices industry cross border deals of November 2020 tracked by GlobalData were:

1) Coloplast’s $145m acquisition of Nine Continents Medical

2) The $65m venture financing of AliveCor by Bold Capital Partners , Khosla Ventures , Omron Healthcare , Qualcomm Ventures and WP Global Partner

3) Cambridge Innovation Capital , Downing Ventures , Innovation Development Oman Holding SAOC, Legal & General Group, Parkwalk Advisors , Puhua Capital , Tencent Holdings and Xeraya Capital Sdn’s $50m venture financing of Congenica

4) The $45m venture financing deal of Wallaby Medical by GL Ventures and Sinovation Ventures

5) Masimo ’s acquisition deal with Lidco Group for $40.27m.